This study is designed to 1) select a dose regimen for continued development and 2) evaluate nanvuranlat versus Physicians Best Choice (PBC) (FOLFOX, FOLFIRI, …

Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)

~Estimated

~$10 – $8,750

J-Pharma Co., Ltd.NCT07265674

Phase 2

A Single Arm Phase II Trial of Zolbetuximab in Combination With mFOLFOX6 or CAPOX Chemotherapy in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers

Subjects will receive zolbetuximab with either CAPOX every 3 weeks or mFOLFOX6 every 2 weeks. The chemotherapy regimen chosen, mFOLFOX6 or CAPOX is per the tre…

Advanced Biliary Tract CancerMetastatic Biliary Tract Carcinoma

~Estimated

~$10 – $7,500

Midhun MallaNCT07723534